Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Nanobio Corporation

Home Clinical Trial Sponsors and OrganizationsNanobio Corporation

Nanobio Corporation

ACTIVE

Private

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

7

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 3

3

42.9%

Phase 1

2

28.6%

Phase 2

2

28.6%

Trial Status Distribution

Completed

6

85.7%

Unknown

1

14.3%

Clinical Trials

Trials sponsored by this organization (7)

NB-001 Treatment of Recurrent Herpes Labialis

Oct 2012362 participants

Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer

May 2011125 participants

A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis

Apr 2011907 participants

A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS)

Apr 2011847 participants

Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008

Mar 2009199 participants

Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis

Feb 20071,000 participants

Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail

Jan 2007443 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials7
Approvals
News

Back to Organizations